154 related articles for article (PubMed ID: 32109341)
21. Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters.
Kikuchi E; Mori T; Zeniya M; Isobe K; Ishigami-Yuasa M; Fujii S; Kagechika H; Ishihara T; Mizushima T; Sasaki S; Sohara E; Rai T; Uchida S
J Am Soc Nephrol; 2015 Jul; 26(7):1525-36. PubMed ID: 25377078
[TBL] [Abstract][Full Text] [Related]
22. Role of the WNK-activated SPAK kinase in regulating blood pressure.
Rafiqi FH; Zuber AM; Glover M; Richardson C; Fleming S; Jovanović S; Jovanović A; O'Shaughnessy KM; Alessi DR
EMBO Mol Med; 2010 Feb; 2(2):63-75. PubMed ID: 20091762
[TBL] [Abstract][Full Text] [Related]
23. Cotransporters, WNKs and hypertension: an update.
Flatman PW
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):186-92. PubMed ID: 18277153
[TBL] [Abstract][Full Text] [Related]
24. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
[TBL] [Abstract][Full Text] [Related]
25. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
Argaiz ER; Chavez-Canales M; Ostrosky-Frid M; Rodríguez-Gama A; Vázquez N; Gonzalez-Rodriguez X; Garcia-Valdes J; Hadchouel J; Ellison D; Gamba G
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F734-F745. PubMed ID: 29846116
[TBL] [Abstract][Full Text] [Related]
26. From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.
Wang Y; O'Connell JR; McArdle PF; Wade JB; Dorff SE; Shah SJ; Shi X; Pan L; Rampersaud E; Shen H; Kim JD; Subramanya AR; Steinle NI; Parsa A; Ober CC; Welling PA; Chakravarti A; Weder AB; Cooper RS; Mitchell BD; Shuldiner AR; Chang YP
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):226-31. PubMed ID: 19114657
[TBL] [Abstract][Full Text] [Related]
27. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of SPAK kinase reduces body weight gain in mice fed a high-fat diet by improving energy expenditure and insulin sensitivity.
Torre-Villalvazo I; Cervantes-Pérez LG; Noriega LG; Jiménez JV; Uribe N; Chávez-Canales M; Tovar-Palacio C; Marfil-Garza BA; Torres N; Bobadilla NA; Tovar AR; Gamba G
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E53-E65. PubMed ID: 29066461
[TBL] [Abstract][Full Text] [Related]
29. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
Vitari AC; Deak M; Morrice NA; Alessi DR
Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
[TBL] [Abstract][Full Text] [Related]
31. A SPAK isoform switch modulates renal salt transport and blood pressure.
McCormick JA; Mutig K; Nelson JH; Saritas T; Hoorn EJ; Yang CL; Rogers S; Curry J; Delpire E; Bachmann S; Ellison DH
Cell Metab; 2011 Sep; 14(3):352-64. PubMed ID: 21907141
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
33. STK39 and WNK1 Are Potential Hypertension Susceptibility Genes in the BELHYPGEN Cohort.
Persu A; Evenepoel L; Jin Y; Mendola A; Ngueta G; Yang WY; Gruson D; Horman S; Staessen JA; Vikkula M;
Medicine (Baltimore); 2016 Apr; 95(15):e2968. PubMed ID: 27082544
[TBL] [Abstract][Full Text] [Related]
34. The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.
Wu A; Wolley M; Stowasser M
J Hum Hypertens; 2019 Jul; 33(7):508-523. PubMed ID: 30723251
[TBL] [Abstract][Full Text] [Related]
35. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
36. Area under the curve analysis of blood pressure reveals increased spontaneous locomotor activity in SPAK knock-in mice: relevance for hypotension induced by SPAK inhibition?
Burgess K; Jovanović S; Sudhir R; Jovanović A
Physiol Rep; 2019 Feb; 7(3):e13997. PubMed ID: 30714348
[TBL] [Abstract][Full Text] [Related]
37. WNK signalling pathways in blood pressure regulation.
Murthy M; Kurz T; O'Shaughnessy KM
Cell Mol Life Sci; 2017 Apr; 74(7):1261-1280. PubMed ID: 27815594
[TBL] [Abstract][Full Text] [Related]
38. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.
Richardson C; Alessi DR
J Cell Sci; 2008 Oct; 121(Pt 20):3293-304. PubMed ID: 18843116
[TBL] [Abstract][Full Text] [Related]
39. Chronic Metabolic Acidosis Activates Renal Tubular Sodium Chloride Cotransporter through Angiotension II-dependent WNK4-SPAK Phosphorylation Pathway.
Fang YW; Yang SS; Cheng CJ; Tseng MH; Hsu HM; Lin SH
Sci Rep; 2016 Jan; 6():18360. PubMed ID: 26728390
[TBL] [Abstract][Full Text] [Related]
40. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
